- 57.2k views
Metabolic syndrome in women with PCOS
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
About the Speaker
Dr. Krishna Kumari
Senior Consultant Gynecologist, Apollo Hospital, Hyderabad
Dr. M. Krishna Kumari is a distinguished Obstetrician and Gynecologist, currently serving as a Professor at Apollo Institute of Medical Sciences and Research. With an MBBS from Andhra University obtained in 1981 and an MD in Obstetrics and Gynecology from the same institution in 1985, where she was honored with the HM Lazarus Gold Medal, Dr. Kumari brings over 35 years of extensive clinical experience and two decades of dedicated teaching. Her expertise encompasses high-risk obstetrics, advanced gynecological procedures, and fertility regulation. Passionate about academics and professional development, Dr. Kumari is an active member of several prestigious organizations, including the Federation of Obstetric & Gynecological Societies of India (FOGSI), the Indian Society of Perinatology and Reproductive Biology (ISOPARB), and the Indian Menopausal Society (IMS). She also served as the President of the Obstetrics & Gynaecological Society of Hyderabad (OGSH) from 2017 to 2019. Dr. Kumari's commitment to her field and her contributions to both clinical practice and medical education make her a respected and influential figure in obstetrics and gynecology.
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Krishna Kumari's Talks on Assimilate
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.
- 11th-June-2024, TIME : 5:00PM - 6:00PM
- 0
Metabolic syndrome is a common and significant concern in women with Polycystic Ovary Syndrome (PCOS), characterized by a cluster of conditions including insulin resistance, obesity, dyslipidemia, and hypertension. These interconnected metabolic disturbances increase the risk of developing cardiovascular diseases and type 2 diabetes. Insulin resistance, a hallmark of PCOS, exacerbates hyperandrogenism, leading to further metabolic and reproductive complications. Women with PCOS often struggle with weight management, contributing to the prevalence of obesity within this population, which in turn aggravates insulin resistance and other metabolic abnormalities. Dyslipidemia, marked by elevated triglycerides and low HDL cholesterol, is frequently observed in these women, further elevating cardiovascular risk. The management of metabolic syndrome in PCOS involves a multifaceted approach, including lifestyle modifications such as diet and exercise, pharmacological interventions like insulin sensitizers (e.g., metformin), and addressing individual components of the syndrome to mitigate long-term health risks. Early detection and comprehensive management of metabolic syndrome are crucial in improving the overall health outcomes for women with PCOS.